Skip to content
    Qiming Venture Partners USA logo

    Qiming Venture Partners USA

    Palo Alto, California, United StatesFounded 2017

    Qiming Venture Partners USA is an entity of Qiming Venture Partners, a firm primarily focused on early-stage and growth-stage investments in the TMT (Technology, Media, Telecom) and Healthcare sectors in China.

    62% of their portfolio is in Biotech & Life Sciences. Deal activity increased 50% year-over-year (3 deals in the last 12 months). Their most common stage is series-a (46% of deals). Average disclosed round size is $67.3M (across 13 rounds with reported amounts).

    Find people at Qiming Venture Partners USA on Goldilocks AI

    Portfolio

    13

    Fund Size

    $550M

    Top Stage

    Series A

    Last 12 Mo

    3

    Team

    AF

    Anna French

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    13 investments
    CompanyRoundAmountDate
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries B$85MJan 2026
    Dualitas Therapeutics, Inc. logoDualitas Therapeutics, Inc.Series A$65MSep 2025
    Rhino Federated Computing logoRhino Federated ComputingSeries A$15MMay 2025
    Umoja Biopharma logoUmoja BiopharmaSeries C$100MJan 2025
    SSoda HealthSeries B$50MDec 2024
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries A$70MJul 2023
    SSoda HealthSeries A$25MSep 2022
    Auron Therapeutics logoAuron TherapeuticsSeries A$48MJul 2022
    Umoja Biopharma logoUmoja BiopharmaSeries B$210MJun 2021
    Kira Pharmaceuticals logoKira PharmaceuticalsSeries B$53.5MJan 2021
    Umoja Biopharma logoUmoja BiopharmaSeries A$53MNov 2020
    LetsGetChecked logoLetsGetCheckedSeries C$71MMay 2020
    LetsGetChecked logoLetsGetCheckedSeries B$30MMay 2019

    Top Co-Investors

    DCVC4 shared
    MPM Capital3 shared
    CaaS Capital2 shared
    Sofinnova Partners2 shared
    Illumina Ventures1 shared
    HLM Venture Partners1 shared
    Deerfield1 shared
    Transformation Capital1 shared

    Last updated: 15 April 2026